1. Home
  2. UGRO vs ONCO Comparison

UGRO vs ONCO Comparison

Compare UGRO & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$4.02

Market Cap

13.2M

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$1.23

Market Cap

755.3K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGRO
ONCO
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
755.3K
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
UGRO
ONCO
Price
$4.02
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
95.5K
5.8M
Earning Date
04-15-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.80
EPS
N/A
N/A
Revenue
$17,399,438.00
$815,371.00
Revenue This Year
$462.72
N/A
Revenue Next Year
$86.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.07
52 Week High
$39.68
$7.65

Technical Indicators

Market Signals
Indicator
UGRO
ONCO
Relative Strength Index (RSI) 34.14 65.59
Support Level $0.28 $0.42
Resistance Level $4.50 $1.87
Average True Range (ATR) 0.62 0.07
MACD -0.02 0.09
Stochastic Oscillator 7.81 93.02

Price Performance

Historical Comparison
UGRO
ONCO

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Share on Social Networks: